2SEVENTY BIO

2seventy bio is an immuno-oncology cell therapy company that discovers and develops therapies used for cancer treatment. The company combines a deep knowledge of cancer cell biology and genetics with an understanding of the immune response to cancer to advance its pipeline. It was established in Cambridge, Massachusetts in 2021.

2SEVENTY BIO

Social Links:

Twitter

Industry:

Biotechnology Genetics Health Care Therapeutics

Founded:

2021-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.2seventybio.com

Total Employee:

251+

Status:

Active

Contact:

617-675-7270

Email Addresses:

[email protected]

Total Funding:

170 M USD

Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

rakuten-medical-logo

Rakuten Medical

Rakuten Medical is a Bio-technology Company.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

tango-therapeutics-logo

Tango Therapeutics

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

cogent-biosciences-logo

Cogent Biosciences

Cogent Biosciences is a biopharmaceutical company that develops therapies for solid cancer tumors.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

vor-biopharma-logo

Vor Biopharma

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

Current Employees Featured

susan-abu-absi_image

Susan Abu-Absi
Susan Abu-Absi Chief Technology & Manufacturing Officer @ 2seventy bio
Chief Technology & Manufacturing Officer
2022-01-01

greg-fralish_image

Greg Fralish
Greg Fralish Vice President, Head of Corporate Development @ 2seventy bio
Vice President, Head of Corporate Development
2021-11-01

nick-leschly_image

Nick Leschly
Nick Leschly Chief Kairos Officer @ 2seventy bio
Chief Kairos Officer
2021-11-01

philip-gregory_image

Philip Gregory
Philip Gregory Chief Scientific Officer @ 2seventy bio
Chief Scientific Officer

steven-h-bernstein_image

Steven H. Bernstein
Steven H. Bernstein CMO @ 2seventy bio
CMO
2022-02-01

nicola-heffron_image

Nicola Heffron
Nicola Heffron Chief Operating Officer @ 2seventy bio
Chief Operating Officer

william-baird_image

William Baird
William Baird Chief Financial Officer @ 2seventy bio
Chief Financial Officer

aura-mackenzie_image

Aura Mackenzie
Aura Mackenzie Senior Director, Oncology Commercial and Program Strategy @ 2seventy bio
Senior Director, Oncology Commercial and Program Strategy
2021-11-01

Stock Details

Company's stock symbol is NASDAQ:TSVT

Investors List

madison-avenue-partners_image

Key Employee Changes

Date	New article
2022-02-14	2seventy bio plucks Turnstone Biologics exec Bernstein to be new CMO

Official Site Inspections

http://www.2seventybio.com Semrush global rank: 2.14 M Semrush visits lastest month: 9.43 K

Host Informations
Whois Informations

Loading ...